Abstract
A persistent concern with CRISPR-Cas9 gene editing has been the potential to generate mutations at off-target genomic sites. While CRISPR-engineering mice to delete a ~360 bp intronic enhancer, here we discovered a founder line that had marked immune dysregulation caused by a 24 kb tandem duplication of the sequence adjacent to the on-target deletion. Our results suggest unintended repair of on-target genomic cuts can cause pathogenic "bystander" mutations that escape detection by routine targeted genotyping assays.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Base Sequence
-
CRISPR-Cas Systems*
-
Cells, Cultured
-
DNA Damage
-
DNA Repair
-
Gene Duplication
-
Gene Editing / methods*
-
Gene Expression Regulation / immunology
-
Interleukin-2 Receptor alpha Subunit / genetics*
-
Interleukin-2 Receptor alpha Subunit / immunology
-
Mice, Inbred NOD
-
Mutation*
-
T-Lymphocytes / immunology*
-
T-Lymphocytes / metabolism
-
T-Lymphocytes, Regulatory / immunology*
-
T-Lymphocytes, Regulatory / metabolism
Substances
-
Il2ra protein, mouse
-
Interleukin-2 Receptor alpha Subunit